Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR1 | P11362 | 8/20 | 0.37 |
| ▸ | FGFR4 | P22455 | 8/20 | 0.37 |
| ▸ | FDPS | P14324 | 1/20 | 0.36 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.35 |
| ▸ | METTL14 | Q9HCE5 | 1/20 | 0.35 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.35 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4751440 | 0.79 | CYP11B1 (0.47) | FGFR1FGFR4FDPSMETTL3METTL14 | |
| SCHEMBL4752076 | 0.73 | FDPS (0.43) | FGFR1FGFR4FDPSP2RX7HDAC6 | |
| SCHEMBL21138186 | 0.72 | TP53 (0.31) | — | |
| SCHEMBL23436498 | 0.67 | ADORA2A (0.66) | FGFR1FGFR4FDPSP2RX7HDAC6 | |
| SCHEMBL7832523 | 0.67 | ADORA2A (0.64) | FGFR1FGFR4FDPSP2RX7HDAC6 | |
| SCHEMBL11596393 | 0.66 | FDPS (0.54) | FGFR1FGFR4FDPSP2RX7HDAC6 | |
| SCHEMBL4751437 | 0.65 | CYP11B1 (0.47) | METTL3METTL14P2RX7ADORA2AADORA1 | |
| SCHEMBL8982987 | 0.65 | ADORA2A (0.68) | FGFR1FGFR4FDPSP2RX7HDAC6 | |
| SCHEMBL31331791 | 0.65 | ADORA2A (0.68) | FGFR1FGFR4FDPSP2RX7HDAC6 | |
| SCHEMBL11596860 | 0.64 | FDPS (0.52) | FGFR1FGFR4FDPSP2RX7HDAC6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008131502-A2 | ANTIVIRAL COMPOUNDS OF THE ADAMANTANE TYPE | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2008-11-06 | — | — | WO | disclosed |